Articles

Videos

Podcasts

Clinical Role

CLL is the most common leukemia in adult patients in the western world, with 21,040 estimated new cases in 2020. 

Updates in Front-Line Treatment of Chronic Lymphocytic Leukemia

For unresectable gastrointestinal stromal tumors, the introduction of imatinib revolutionized treatment. 

Updates in Management of Gastrointestinal Stromal Tumors

Urothelial carcinoma is the sixth most common cancer diagnosis in the United States, with an estimated 81,400 new diagnoses in 2020 and 17,980 deaths. 

Erdafitinib, Enfortimab Vedotin Offer New Treatments for Metastatic Urothelial Carcinoma

Scripta surveyed 372 respondents between 18 and 60 years of age about American attitudes and behaviors around prescription drug pricing.

Survey Finds Consumers in Pain Over High Prescription Prices, In Need of Better Tools

Ependymoma is a rare type of tumor that develops in the brain or spinal cord and can occur at any age, but occurs most frequently in young children.


FDA Grants Rare Pediatric Disease Designation to Treatment for Ependymoma

Oral chemotherapies can be effective treatments for children with low-grade gliomas, although clinicians should consider available formulations and administration schedules. 

Expert: Consider Oral Chemotherapies for Pediatric Patients With Low-Grade Gliomas

Home infusion within the larger ambulatory infusion setting poses some specific advantages and disadvantages in relation to the other location options available.

Assessing the Advantages, Disadvantages of Intravenous Cancer Therapies in the Home 

In each trial, overall response rate and median progression-free survival in the novel treatment arm showed significant improvement over the sunitinib treatment arm in patients with renal cell carcinoma. 

Study: Four Treatment Options for Renal Cell Carcinoma Prove More Effective Than Sunitinib Monotherapy

Lakesha M. Butler, PharmD, BCPS, diversity and inclusion coordinator and clinical professor at Southern Illinois University Edwardsville, discussed causes of health inequity and how pharmacists can prevent and mitigate them to improve patient outcomes.

HOPA Keynote Speaker Addresses Structural Racism in Pharmacy

A drug recycling program can help increase patient access and minimize waste of expensive oral cancer medications.

Hospital